Haloperidol Dosing Strategies in the Treatment of Delirium in the Critically-Ill
- 26 October 2011
- journal article
- review article
- Published by Springer Nature in Neurocritical Care
- Vol. 16 (1) , 170-183
Abstract
Delirium is the most common mental disturbance in critically-ill patients and results in significant morbidity and mortality. Haloperidol is a preferred agent for the treatment of delirium in this population because of its rapid onset of action and lack of hemodynamic effects. Despite its widespread use in the critical care setting, most of the relevant data are obtained from case series or extrapolated from non-critically-ill populations. This review provides an overview of haloperidol pharmacokinetics and a comprehensive summary of the evidence for various haloperidol dosing regimens in the treatment of delirium in critically-ill patients. A comprehensive literature search was conducted in Medline, Embase, and International Pharmaceutical Abstracts with “haloperidol”, “delirium”, “agitation”, “critically-ill”, and “intensive care” as keywords. Studies involving haloperidol for delirium prophylaxis, non-critical care settings, and terminally-ill subjects were excluded. Eleven studies were identified: four with intermittent IV haloperidol, four with continuous IV infusion haloperidol, two with oral/enteral haloperidol, and one with IM haloperidol. All of the case reports, case series, and descriptive studies have shown a benefit with haloperidol, but publication bias is likely present. Only three studies were controlled studies, but all had small sample sizes and methodological flaws. Randomized, double-blind, active-comparator trials of haloperidol with allocation concealment are needed. Subsequent research should focus on using validated delirium screening and assessment scales for more objective identification and measurement of delirium outcomes.Keywords
This publication has 64 references indexed in Scilit:
- Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trialCritical Care, 2009
- Pharmacological Management of Delirium in Hospitalized Adults – A Systematic Evidence ReviewJournal of General Internal Medicine, 2009
- Occurrence of delirium is severely underestimated in the ICU during daily careIntensive Care Medicine, 2009
- Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care UnitJAMA, 2004
- Pharmacokinetic and Pharmacodynamic Considerations When Treating Patients with Sepsis and Septic ShockClinical Pharmacokinetics, 2002
- Clinical Pharmacokinetics of AntipsychoticsThe Journal of Clinical Pharmacology, 1994
- Continuous infusion of haloperidol controls agitation in critically ill patientsCritical Care Medicine, 1994
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1989
- Haloperidol DecanoateDrugs, 1987
- Rapid Tranquilization of Acutely Psychotic Patients with Intramuscular Haloperidol and ChlorpromazinePsychosomatics, 1973